Florida Laboratory Agrees to Pay $9.8M to Resolve False Claims Act Liability Relating to Self-Disclosure of Compensation Arrangements

NeoGenomics Laboratories, a Florida-based lab company, has agreed to pay nearly $9.8 million to settle False Claims Act allegations stemming from improper financial relationships with referring healthcare providers. The government alleged NeoGenomics offered below-market-value consulting arrangements to providers who sent patients to its labs, and paid referral-based variable compensation to independent consultants for generating those referrals. The DOJ noted that NeoGenomics received cooperation credit for self-disclosing the conduct and assisting with the investigation.

Read full article at U.S. Department of Justice ↗

About this summary. The text above is a short summary written for this site. The original article is hosted by U.S. Department of Justice at the link above; this site does not reproduce the full article. Verify against the source before relying on specific details.